medigraphic.com
ISSN 1561-3070 (Electronic)

2019, Number 1

<< Back Next >>

Rev Cub Oftal 2019; 32 (1)

Intracameral mydriatics in cataract surgery

Cuan AY, Montero DE, Álvarez MJ, Pérez CE, Cárdenas DT, Hormigó PIF

Language: Spanish
References: 29
Page: 1-12
PDF size: 144.04 Kb.


ABSTRACT

In cataract surgery, induction and maintenance of an adequate degree of pupil dilation (mydriasis) throughout the operation are critical elements for the successful removal and replacement of the crystalline lens. A small pupil or pupil closure during surgery pose a technical challenge and increase the risk of intraoperative complications. This is the reason why adequate, maintained mydriasis has remained to this day a fundamental pillar to maximize both safety and satisfactory refractive results in modern cataract surgery. Mydriasis is normally achieved with the previous application of anticholinergic and sympathomimetic eye drops, for which the waiting time for pupil dilation is often longer than the surgical procedure, they have significant systemic absorption which may increase the risk of cardiovascular side effects, and the mydriatic effect tends to vanish during surgery. A bibliographic review was conducted with the purpose of accessing updated information about the most commonly used intracameral mydriatic drugs, their doses and modes of application during cataract surgery.


REFERENCES

  1. Lawuyi LE, Gurbaxani A. The clinical utility of new combination phenylephrine/ketorolac injection in cataract surgery. Clin Ophthalmol. 2015;9:1249–54.

  2. Davey K, Chang B, Purslow C, Clay E, Vataire A. Budget impact model of Mydrane®, a new intracameral injectable used for intraoperative mydriasis, from a UK hospital perspective. BMC Ophthalmology. 2018;18:104. Acceso: 16/01/2019. Disponible en: https://doi.org/10.1186/s12886-018-0746-x

  3. Hashemi H, Seyedian MA, Mohammadpour M. Small pupil and cataract surgery. Curr Opin Ophthalmol. 2015;26(1):3-9.

  4. Guzek JP, Holm M, Cotter JB, et al. Risk factors for intraoperative complications in 1,000 extracapsular cataract cases. Ophthalmology. 1987;94(5):461-6.

  5. Ajay K, Saranya S, Sundaresh DD, Hithashree HR, Hemalatha BC, Krishnaswamy M, et al. Efficacy and safety of intraoperative intracameral mydriasis in manual small incision cataract surgery - A randomized controlled trial. Indian J Ophthalmol. 2017;65:584-8.

  6. Sathish Srinivasan. Intracameral mydriatics during cataract surgery. J Cataract Refract Surg. 2018;44(3):257-8.

  7. Arshinoff SA, Opalinski YAV. The pharmacotherapy of cataract surgery. In: Yanoff M, Duker JS, editors. Ophthalmology. St Louis (MO): Mosby Elsevier: 2008. pp. 434–40.

  8. Cortés C, Cuesta T, Gil M. Capítulo 32. Fármacos midriáticos: pautas de dilatación en cirugía de cristalino. En: Lorente R, Mendicute J. Cirugía del cristalino: LXXXIV ponencia oficial de la Sociedad Española de Oftalmología, 2008. Madrid: Sociedad Española de Oftalmología; 2008. p. 421-7.

  9. Álvarez-Rementería L. Midriáticos intracamerulares durante la facoemulsificación. En: Lorente R, Mendicute J. Cirugía del cristalino: LXXXIV ponencia oficial de la Sociedad Española de Oftalmología, 2008. Madrid: Sociedad Española de Oftalmología; 2008. p. 464-70.

  10. Rajesh Subhash Joshi. Phacoemulsification without preoperative mydriasis in patients with age-related cataract associated with type 2 diabetes. Clin Ophthalmol. 2016;10: 2427-32.

  11. Chang DF, Campbell JR. Intraoperative floppy iris syndrome associated with tamsulosin. J Cataract Refract Surg. 2005;31:664-73.

  12. Lundberg B, Behndig A. Intracameral mydriatics in phacoemulsification cataract surgery. J Cataract Refract Surg. 2003;29:2366-71.

  13. Lundberg B, Behndig A Separate and additive mydriatic effects of lidocaine hydrochloride, phenylephrine, and cyclopentolate after intracameral injection. J Cataract Refract Surg. 2008;34:280-3.

  14. Nikeghbali A, Falavarjani KG, Kheirkhah A. Pupil dilation with intracameral lidocaine during phacoemulsification: benefits for the patient and surgeon. Indian J Ophthalmol. 2008;56:63-4.

  15. Myers WG, Shugar JK. Optimizing the intracameral dilation regimen for cataract surgery: prospective randomized comparison of 2 solutions. J Cataract Refract Surg. 2009;35:273-6.

  16. Labetoulle M. Evaluation of the efficacy and safety of a standardised intracameral combination of mydriatics and anaesthetics for cataract surgery. Br J Ophthalmol. 2016 Acceso: 23/02/2018;100:976-85. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941138/pdf/bjophthalmol-2015- 307587.pdf

  17. Gunnie Backstrom, Anders Behndig. Redilatation with intracameral mydriatics in phacoemulsification surgery. Acta Ophthalmol Scand. 2006;84:100-4.

  18. Gurbaxani A, Packard R. Intracameral phenylephrine to prevent floppy iris syndrome during cataract surgery in patients on tamsulosin. Eye. 2007;21(3):331-2.

  19. Lorente R. Intracameral phenylephrine 1,5 % for prophylaxis against intraoperative floppy iris syndrome: prospective, randomized fellow eye study. Ophthalmology. 2012;119(10):2053-8.

  20. Williams G, Radwan M, Kadare S, Williams C. The short to medium-term risks of intracameral phenylephrine. Middle East Afr J Ophthalmol. 2012;19(4):357-60.

  21. Cionni RJ, Barros MG, Kaufman AH, Osher RH. Cataract surgery without preoperative eyedrops. J Cataract Refract Surg. 2003;29:2281-3.

  22. Benatar-Haserfaty J, Álvarez de Rementería-Fernández L, Muriel A. Facoemulsificación sin midriasis preoperatoria: beneficios para el paciente. Arch Soc Esp Oftalmol. 2004;79:53-8.

  23. American Society of Cataract and Refractive Surgery. Alerta Clínica en Estados Unidos: uso de epinefrina para mantener la midriasis durante la cirugía de cataratas. News room. December 13, 2017. Acceso: 15/12/2018. Disponible en: http://www.ascrs.org/aboutascrs/ news-about/clinical-alert-intraocular-use-epinephrine-maintain-mydriasis-duringcataract- surgery

  24. Grob SR, González-González LA; Daly MK. Management of mydriasis and pain in cataract and intraocular lens surgery: review of current medications and future directions. Clin Ophthalmol. 2014;8:1281-9.

  25. Hoffman RS, Braga-Mele R, Donaldson K. Cataract surgery and nonsteroidal antinflammatory drugs. J Cataract Refract Surg. 2016;42(9):1368–79. doi: 10.1016/j.jcrs.2016.06.006 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531861

  26. Won Jung J, Hoon Chung B, Kweon Kim E, Yul Seo K, Tae-im Kim. The effects of two non-steroidal antinflammatory drugs, bromfenac 0.1 % and ketorolac 0.45 % on cataract surgery. Yonsei Med J. 2015;56(6):1671-7.

  27. Chiambaretta F. Pupil dilation dynamics with an intracameral fixed combination of mydriatics and anesthetic during cataract surgery. J Cataract Refract Surg. 2018;44(3):341- 7. doi: 10.1016/j.jcrs.2017.12.025

  28. Hovanesian JA. Intracameral phenylephrine and ketorolac during cataract surgery to maintain intraoperative mydriasis and reduce postoperative ocular pain: integrated results from 2 pivotal phase 3 studies. J Cataract Refract Surg. 2015;41:2060-8.

  29. Rosenberg ED. Visual outcomes, efficacy and surgical complications associated with intracameral phenylephrine 1.0 %/ ketorolac 0.3 % administered during cataract surgery. Clin Ophthalmol. 2018;12:21-8.




2020     |     www.medigraphic.com